Corrigendum highlights FOLR1's impact on glioblastoma malignancy, suggesting a key regulatory axis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: